Trials / Conditions / Combined Hepatocellular-cholangiocarcinoma
Combined Hepatocellular-cholangiocarcinoma
4 registered clinical trials studyying Combined Hepatocellular-cholangiocarcinoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Phase II Clinical Study on the Efficacy and Safety of the Combination of Cadonilimab and Capecitabine in Adjuv NCT07243951 | Shanghai Zhongshan Hospital | Phase 2 |
| Recruiting | Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcino NCT06849180 | Zhongda Hospital | — |
| Not Yet Recruiting | Gemox Combined With Anlotinib and Sintilimab in Advanced cHCC-ICC NCT06033118 | Sichuan University | Phase 1 / Phase 2 |
| Withdrawn | Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer NCT05292443 | Geneplus-Beijing Co. Ltd. | — |